Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease

European Journal of Endocrinology

Volumn 163, Issue 1, 2010, Pages 35-43

  Raverot, Gérald ^a,b,c   Wierinckx, Anne ^a,b,d   Jouanneau, Emmanuel ^a,b,c   Auger, Carole ^a,b   Borson Chazot, Françoise ^b,c   Lachuer, Joël ^a,b,d   Pugeat, Michel ^b,c   Trouillas, Jacqueline ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d ProfileXpert   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; MESSENGER RNA;

ACTH SECRETING ADENOMA; ACTH SECRETING CELL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; FEMALE; GENE EXPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SILENT CORTICOTROPH ADENOMA; TUMOR DIAGNOSIS;

EID: 77954108320     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0076     Document Type: Article

References (33)

1. Trouillas J, Barkan AL, Watson REJ, Lindell EP, Farrell WE & Lloyd RV. ACTH pituitary adenoma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs, pp 26-29. Eds RA DeLellis, RV Lloyd, PU Heitz & C Eng, Lyon: IARC Press, 2004.
2. Trouillas J. Pathology and pathogenesis of pituitary corticotroph adenoma. Neurochirurgie 2002 48 149-162. (Pubitemid 34606329)
3. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME & Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. American Journal of Pathology 1980 98 617-638. (Pubitemid 10154792)
4. Horvath E, Kovacs K, Smyth HS, Killinger DW, Scheithauer BW, Randall R, Laws ER Jr & Singer W. A novel type of pituitary adenoma: morphological features and clinical correlations. Journal of Clinical Endocrinology and Metabolism 1988 66 1111-1118.
5. Tourniaire J. The so-called silent corticotropic pituitary adenoma. Presse Médicale 1991 20 197-198.
6. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV,Meyer FB, Laws ER Jr & Young WF Jr. Clinically silent corticotroph tumours of the pituitary gland. Neurosurgery 2000 47 723-729 discussion 729-730. (Pubitemid 32044719)
7. Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S & Hirata Y. Differential gene expression in ACTH-secreting and non-functioning pituitary tumours. European Journal of Endocrinology 2007 157 717-724.
8. Webb KM, Laurent JJ, Okonkwo DO, Lopes MB, Vance ML & Laws ER Jr. Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery 2003 53 1076-1084 discussion 1084-1075.
9. Reincke M, Allolio B, Saeger W, Kaulen D & Winkelmann W. A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1987 65 1296-1300. (Pubitemid 18026874)
10. Cottier J-P, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M & Herbreteau D. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology 2000 215 463-469. (Pubitemid 30237846)
11. Abou Samra AB, Dechaud H, Estour B, Chalendar D, Fevre-Montange M, Pugeat M & Tourniaire J. Beta-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity. Journal of Clinical Endocrinology and Metabolism 1985 61 116-119. (Pubitemid 15046204)
12. Brun J, Chamba G, Khalfallah Y, Girard P, Boissy I, Bastuji H, Sassolas G & Claustrat B. Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. Journal of Sleep Research 1998 7 105-114. (Pubitemid 28329037)
13. Murphy BE. Clinical evaluation of urinary cortisol determinations by competetive protein-binding radioassay. Journal of Clinical Endocrinology and Metabolism 1968 28 343-348.
14. Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K & Sano T. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 2007 61 580-584 discussion 584-585. (Pubitemid 47442650)
15. Baldeweg SE, Pollock JR, Powell M & Ahlquist J. A spectrum of behaviour in silent corticotroph pituitary adenomas. British Journal of Neurosurgery 2005 19 38-42. (Pubitemid 40824371)
16. Korbonits M & Carlsen E. Recent clinical and pathophysiological advances in non-functioning pituitary adenomas. Hormone Research 2009 71 (Suppl 2) 123-130.
17. Cho HY, Cho SW, Kim SW, Shin CS, Park KS & Kim SY. Silent corticotroph adenomas have unique recurrence characteristics as compared with other non-functioning pituitary adenomas. Clinical Endocrinology 2009 72 648-653.
18. Blevins LS Jr, Christy JH, Khajavi M & Tindall GT. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. Journal of Clinical Endocrinology and Metabolism 1998 83 63-67. (Pubitemid 28498311)
19. Selvais P, Donckier J, Buysschaert M & Maiter D. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. European Journal of Endocrinology 1998 138 153-159. (Pubitemid 28131091)
20. Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM & Grossman AB. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. Journal of Clinical Endocrinology and Metabolism 2005 90 4963-4969. (Pubitemid 41159397)
21. Trouillas J, Girod C, Sassolas G, Vitte PA, Claustrat B, Perrin G, Lheritier M, Fischer C & Dubois MP. A human beta-endorphin pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 1984 58 242-249.
22. Jin L, Riss D, Ruebel K, Kajita S, Scheithauer BW, Horvath E, Kovacs K & Lloyd RV. Galectin-3 expression in functioning and silent ACTH-producing adenomas. Endocrine Pathology 2005 16 107-114. (Pubitemid 41400351)
23. Thodou E, Argyrakos T & Kontogeorgos G. Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas. Hormones 2007 6 227-232.
24. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M & Klibanski A. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Journal of Clinical Endocrinology and Metabolism 1998 83 1619-1623. (Pubitemid 28501032)
25. Gibson S, Ray DW, Crosby SR, Dornan TL, Jennings AM, Bevan JS, Davis JR & White A. Impaired processing of proopiomelanocortin in corticotroph macroadenomas. Journal of Clinical Endocrinology and Metabolism 1996 81 497-502. (Pubitemid 26055653)
26. Ohta S, Nishizawa S, Oki Y, Yokoyama T & Namba H. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I - immunohistochemical study. Pituitary 2002 5 221-223. (Pubitemid 37184442)
27. Tateno T, Izumiyama H, Doi M, Akashi T, Ohno K & Hirata Y. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma. Endocrine Journal 2007 54 777-782. (Pubitemid 351377757)
28. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, Enjalbert A, Drouin J & Brue T. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. Journal of Clinical Endocrinology and Metabolism 2003 88 3050-3056. (Pubitemid 36877471)
29. Grossman AB. The molecular biology of pituitary tumours: a personal perspective. Pituitary 2009 12 265-270.
30. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, Meij B & Drouin J. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes and Development 2006 20 2871-2886.
31. Drouin J, Bilodeau S & Vallette S. Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency. Clinical Genetics 2007 72 175-182. (Pubitemid 47300017)
32. Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF Jr, Vidal S, Kovacs K, Raz A & Lloyd RV. Differential expression of galectin-3 in pituitary tumours. Cancer Research 2003 63 2251-2255.
33. Honjo Y, Nangia-Makker P, Inohara H & Raz A. Down-regulation of galectin-3 suppresses tumourigenicity of human breast carcinoma cells. Clinical Cancer Research 2001 7 661-668.